MDXH MDxHealth


$ 4.28 $ 0.19 (4.62 %)    

Wednesday, 15-Oct-2025 15:59:55 EDT
QQQ $ 603.07 $ 4.22 (0.71 %)
DIA $ 462.77 $ 0.00 (0 %)
SPY $ 665.59 $ 2.94 (0.44 %)
TLT $ 90.71 $ -0.20 (-0.22 %)
GLD $ 387.50 $ 6.60 (1.73 %)
$ 4.3
$ 4.12
$ 3.90 x 5
$ 4.78 x 10
$ 4.10 - $ 4.30
$ 1.35 - $ 4.94
144,876
na
nm
$ -549,628.12
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mdxhealth-affirms-fy2025-sales-guidance-of-10800m-11000m

MDxHealth (NASDAQ:MDXH) affirms FY2025 sales outlook from $108.00 million-$110.00 million to $108.00 million-$110.00 million.

 mdxhealth-q1-eps-019-misses-013-estimate-sales-2430m-beat-2411m-estimate

MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.13) b...

 mdxhealth-affirms-fy2025-sales-guidance-of-10800m-11000m-vs-10625m-est

MDxHealth (NASDAQ:MDXH) affirms FY2025 sales outlook from $108.00 million-$110.00 million to $108.00 million-$110.00 million vs...

 mdxhealth-q4-eps-014-beats-019-estimate-sales-2474m-beat-2336m-estimate

MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.19) by ...

 mdxhealth-expects-q4-revenue-of-247m-and-fy24-revenue-of-900m-both-up-by-28-yoy-expects-fy25-revenue-of-108m-110m-up-by-20-22-yoy-and-eyes-adj-ebitda-profitability-in-first-half

MDxHealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today repor...

 piper-sandler-maintains-overweight-on-mdxhealth-lowers-price-target-to-6

Piper Sandler analyst Jason Bednar maintains MDxHealth (NASDAQ:MDXH) with a Overweight and lowers the price target from $8 t...

 mdxhealth-raises-fy2024-sales-guidance-from-8500m-8700m-to-8700m-8900m--vs-est-8568m

MDxHealth (NASDAQ:MDXH) raises FY2024 sales outlook from $85.00 million-87.00 million to $87.00 million-89.00 million.

 mdxhealth-q3-eps-040-misses-027-estimate-sales-2332m-beat-2148m-estimate

MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.27) b...

 lake-street-initiates-coverage-on-mdxhealth-with-buy-rating-announces-price-target-of-7

Lake Street initiates coverage on MDxHealth (NASDAQ:MDXH) with a Buy rating and announces Price Target of $7.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION